11 Panel Card (OPI 300) w/Adult, Item No. 71125AA
Published December 30, 2015 · Recall initiated: November 16, 2015
Summary
FDA records medical device Class III recall Z-0487-2016, published December 30, 2015 and initiated November 16, 2015. Recalling firm: Ameditech Inc; Status: Terminated; Reported quantity: 50 kits; Lot: 144376. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Ameditechs Drugs of Abuse Tests listed above have shown reduced reactivity for up to two (2) of the nineteen (19) Benzodiazepine (BZO) compounds for which specificity information is provided in the product insert. The particular BZO compounds for which there may be reduced reactivity are Clonazepam and Chlordiazepoxide.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Ameditech Inc
- Distributor
- Nationwide Distribution.
- Lot
- 144376
- Risk classification
- Class III
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAImmuTest Drugs of Abuse Cup (AMT Item Number/ AMT Description): IMCA-5AB-W / "ImmuTest Drugs of Abuse CupOctober 7, 2020
- FDANoble 1 Step+ Cup (AMT Item Number/ AMT Description): NBCA-13A-B /"Noble 1 Step + Cup" THC50/COC150;October 7, 2020
- FDAFirst Check 7 Panel Drug Cup: (AMP/COC/MDMA/MET/OPI/PCP/THC); AMT Item Number 990100BOctober 7, 2020
- FDADrug Screening Component: Uncut Sheets Part Number/ Description/ LOT Number 100163/ EDI OPI (300) UncutOctober 7, 2020
- FDA10-Panel Pipette Drug Screen, Item No. PSP-10MDecember 30, 2015
- FDABZO Strip Dip Card (300ng/ml)*, Item No. 100170December 30, 2015
Questions about this recall
Was 11 Panel Card (OPI 300) w/Adult, Item No. 71125AA recalled?
Yes. FDA published recall Z-0487-2016 on December 30, 2015. Reported hazard: Ameditechs Drugs of Abuse Tests listed above have shown reduced reactivity for up to two (2) of the nineteen (19) Benzodiazepine (BZO) compounds for which specificity information is provided in the product insert. The particular BZO compounds for which there may be reduced reactivity are Clonazepam and Chlordiazepoxide.
What should I do if I have this product?
Voluntary: Firm initiated · Letter